I am assuming the community is wondering, who the heck is Benjamin Terry, the guy who runs a lab that randomly tweeted about a collaboration about an oral drug delivery system developed at Terry Labs with Progenity. Then he randomly tags Pfizer and JNJinnovation. Then...radio silence. The Progenity community is left wondering, is this some kind of cryptic message? A breadcrumb leading to some kind of an announcement.

Terry Research Lab looks to be some kind of lab out of University of Nevada that specializes in biotechnology. I tried to uncover some kind of connection between Benjamin, pfizer, abbvie, eli lilly, anything that can point to where this is headed.

It seems that that Terry holds a significant number of patents. Most recently (https://patents.google.com/patent/US20170027520?oq=benjamin terry progenity) in 2015. This work heavily cites progenity's patents, and relates to GI implantation of a bio-delivery device.

Interestingly the Assignee is NuTech Ventures. According to their site, NuTech is a "nonprofit technology commercialization affiliate of the University of Nebraska" that "evaluates, protects, markets and licenses the university’s intellectual property to promote economic development and improve quality of life".

Their board seems stacked, but most notably is Ronnie Green, Chancellor of UNL. He also served as senior global director of technical services for Pfizer.

There seems to be some connection between TRL/Benjamin Terry and NuTech Ventures. But if NuTech specializes in the commercialization of technology and is served by individuals with connections to pfizer...could this be a connection? Could pfizer, nutech, and TRL be working with progenity for the commercialization of their products?